Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Reexamination Certificate
2008-09-30
2008-09-30
Campell, Bruce (Department: 1648)
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
C435S239000, C435S239000, C435S261000, C435S041000, C435S042000
Reexamination Certificate
active
11390885
ABSTRACT:
A simple and efficient method of producing mammalian reovirus is developed using HEK 293 cells. The method provides for fast production of reovirus in high yield. Furthermore, this method provides for a simpler purification procedure of the produced reovirus.
REFERENCES:
patent: 4070453 (1978-01-01), Bordt et al.
patent: 4559229 (1985-12-01), Page et al.
patent: 5023252 (1991-06-01), Hsei
patent: 5658779 (1997-08-01), Krupey et al.
patent: 6136307 (2000-10-01), Lee et al.
patent: 6528305 (2003-03-01), Thompson et al.
patent: 6726907 (2004-04-01), Zhang et al.
patent: 2283894 (1999-02-01), None
patent: 2360833 (2000-08-01), None
patent: 2407894 (2001-11-01), None
patent: 0727484 (1996-08-01), None
patent: 63044532 (1988-02-01), None
patent: 8-214876 (1995-08-01), None
patent: WO 99/08692 (1999-02-01), None
Levin et al. Proc. Nat. Acad. Sci. 1970, vol. 66, No. 3, pp. 890-897.
Berry et al., “Production of Reovirus Type-1 and Type-3 from Vero Cells Grown on Solid and Macroporous Microcarriers,”Biotechnology and Bioengineering62, (1999), pp. 12-19.
Bos, J. L., “Ras Oncogenes in Human Cancer: A Review,”Canc. Res., 49(17), pp. 4682-4689, (1989).
Chandron and Nibert, “Protease cleavage of reovirus capsid protein μ1 and μ1C is blocked by alkyl sulfate detergents, yielding a new type of infectious subvirion particle,”J. of Virology, 72(1), (1998), pp. 467-475.
Coffey, M.C., et al., “Reovirus therapy of tumors with activated Ras pathway,”Science282, (1998), pp. 1332-1334.
Hand, et al.,J. Gen. Virol., 12:121-130 (1971).
Hand, et al.,J. Mol. Biol., 82:175-183 (1974).
Drastini, Y., et al., “Comparison of eight different procedures for harvesting avian reoviruses grown in Vero cells,”J. of Virological Methods, 39, (1992), pp. 269-278.
Jones, R.C., et al., “Different sensitivities of Vero cells from two sources to avian reoviruses,”Research in Veterinary Science, 48, (1990), pp. 379-380.
Joklik, W.K., et al., “Anti-thyroglobulin antibodies induced with recombinant reovirus infection in BALB/c mice,”J. Biol. Chem., 270:4181-4184 (1995).
Keirstead et al., “Absence of superinfection exclusion during asynchronous reovirus infections of mouse, monkey, and human cells”, Virus Research, 54, 1998, pp. 225-235.
McRae, M.A. and Joklik, W.K., “The nature of the polypeptide encoded by each of the 10 double-stranded RNA segments of reovirus type 3,”Virology, 89, (1979), pp. 578-593.
Meanger, J., et al., “Immune response to avian reovirus ain chickens and protection against experimental infection,”Aust. Vet. J., 75(6), (Jun. 1997), pp. 428-432.
Nwajei, B.N.C., et al., “Comparison of chick embryo liver and Vero cell cultures for the isolation and growth of avian reoviruses,”Avian Pathology, 17, (1988), pp. 759-766.
T. Orodera et al., “Recombination Between Temperature-Sensitive and Deletion Mutants of Reovirus,”Immunology, 71:581-585 (1990).
Poggioli, et al.,J. Virol., 74:9562-9570 (2000).
Smith, R.E., et al., “Polypeptide components of virions, top component and cores of reovirus type 3,”Virology, 39, (1969), pp. 791-810.
Spandidos, D. et al., “What Reassorts When Reovirus Genome Segments Reassort?”J. Virology, 18:117-123 (1976).
Strong, J.E. and P.W. Lee, “Thev-erbBoncogene confers enhanced cellular susceptibility to reovirus infection,”J. Virol., 70, (1996), pp. 612-616.
Strong, J.E., et al., “Evidence that the Epidermal Growth Factor Receptor on Host Cells Confers Reovirus Infection Efficiency Virology,” 197(1), (1993), pp. 405-411.
Strong, J.E., et al., “The molecular basis of viral oncolysis: usurpation of the Ras signaling pathway by reovirus,”EMBO J., 17, (1998), pp 3351-3362.
Taber et al., “The selection of virus-resistant Chinese hamster ovary cells,”Cell, 8, (1976), pp. 529-533.
Tyler, et al. ,“Reoviruses,”Encyclopedia of Virology, 2ndedition, lines 4-14 on right column of p. 1456 (1999).
Wilcox, G.E., et al., “Adaptation and characteristics of replication of a strain of avian reovirus in Vero cells,”Avian Pathology, 14, (1985), pp. 321-328.
Wyatt R.G. et al., “Probable in vitro cultivation of human reovirus like agent of infantile diarrhoea,”Lancet(1976) 1/7950:98-99.
2002 American Type Culture collection (ATCC) at http://www.atcc.org/Search catalogs?searchAll.cfm.
Mora, M. et al. “Association of reovirus proteins with structural matrix of infected cells”, Virology 159: 265-277 (1987).
Hitt, M, et al. “Construction and propagation of human adenovirus vectors”, Cell Biology vol. 1, third ed. pp. 500-512 (1998).
Barta, V.; Springer, W.T.; Millar, D.L. A comparison of avian and mammalian cell cultures for the propagation of avian reovirus WVU 2937. Avian Dis., 28(1) 216-223, 1984.
Coffey Mathew C.
Thompson Bradley G.
Campell Bruce
Li Bao Qun
Oncolytics Biotech Inc.
LandOfFree
Method of producing infectious reovirus does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method of producing infectious reovirus, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method of producing infectious reovirus will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3938108